Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Demonstration of a Digital Care Program for Methamphetamine Use Disorder

NCT05206175 is registered in ClinicalTrials.gov with Affect Therapeutics, Inc. as lead sponsor.

NCT NCT05206175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05206175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Demonstration of a Digital Care Program for Methamphetamine Use Disorder
Lead sponsor
Affect Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 14, 2022
Completion date
December 31, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse